New Study Finds Screening HIV Patients for Cryptococcal Antigen Saves Lives
2015 AACC Annual Meeting Press ProgramThe CrAg Lateral Flow Assay (LFA) a novel, rapid diagnostic test, is playing a crucial role in saving lives all over the world. The CrAg LFA tests for an infection called Cryptococcosis, which kills over 600,000 people every year, primarily in HIV/AIDS patients. Because of the ease-of-use and room temperature storage, the CrAg LFA, developed by IMMY, is the only test capable of bridging the gap between this disease and the life-saving medicine these patients need.